Treatment and clinical outcomes of pediatric autoimmune hemolytic anemia: real-world single-center data from Korea
Background Autoimmune hemolytic anemia (AIHA) is rare and characterized by hemolytic anemia with a positive direct antiglobulin test result after the exclusion of other causes. While adults often relapse within 1 year of first-line steroid therapy, children generally respond well. However, current t...
Saved in:
| Main Authors: | Young Dai Kwon, Eun Sun Jung, Yeon Jung Lim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Pediatric Society
2025-07-01
|
| Series: | Clinical and Experimental Pediatrics |
| Subjects: | |
| Online Access: | http://e-cep.org/upload/pdf/cep-2024-02026.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autoimmune Hemolytic Anemia in the Course of Pediatric Acute Leukemia and After Hematopoietic Stem Cell Transplantation
by: Sırma Karamercan, et al.
Published: (2025-07-01) -
Coexistent sickle cell anemia and autoimmune hemolytic anemia in two adolescents
by: Vinícius Reis Soares, et al.
Published: (2024-11-01) -
Autoimmune Hemolytic Anemia as Presentation of Celiac Disease
by: Ahmed Abdul Hadi Mohsen, et al.
Published: (2022-12-01) -
Severe autoimmune hemolytic anemia in Covid-19 infection
by: Fehmi Hindilerden, et al.
Published: (2020-06-01) -
Case report on autoimmune hemolytic anemia: A mask of malignancy!
by: Abhilasha Sampagar, et al.
Published: (2020-01-01)